Financial calendar 2014

Date Event
28 August 2014 Half year results 2014
13 November 2014 Q3 2014 results

Closed periods(*):

2014/01/27 – 2014/02/28; 2014/04/30 – 2014/05/15; 2014/08/14 – 2014/08/29; 2014/10/30 – 2014/11/14

(*)Please note that any given permission to trade shall in any event expire on the third business day (at 24:00 hours) before any closed period.

Key financials

(€'000) 2013 2012 2011 2010 2009 2008 2007
R&D income 33,181 25,645 19,861 29,196 28,068 15,557 8,785
Grants 2,761 1,082 2,008 2,263 1,615 1,198 1,135
Total revenues 35,942 26,727 21,869 31,432 29,683 16,755 9,920
R&D expenses (43,699) (46,868) (56,307) (48,512) (42,800) (29,889) (18,750)
G&A expenses (10,044) (9,409) (10,423) (8,882) (9,044) (7,447) (5,482)
Total expenses (53,743) (56,277) (66,730) (57,394) (51,844) (37,336) (24,232)
Other operating income/(expense) 128 (222) (668) 97 1 6 5
Operating result (17,673) (29,772) (45,529) (25,865) (22,160) (20,575) (14,307)
Net financial result (1,797) 1,264 1,634 1,395 2,165 5,352 1,785
Result before taxes (19,470) (28,508) (43,895) (24,470) (19,995) (15,223) (12,522)
Income tax expense 0 0 0 0 0 0 0
Net result of the year (19,470) (28,508) (43,895) (24,470) (19,995) (15,223) (12,522)
Basic and diluted loss per share (0.41) (0.65) (1.01) (0.58) (0.54) (0.42) (0.49)

Financial reports

Annual reports

Annual report 2013Annual report 2013
Annual report 2012Annual report 2012printer-friendly version
Annual report 2011Annual report 2011
Annual report 2010
Annual report 2009
Annual report 2008
Annual report 2007


Interim reports
Half-year financial report 2013
Half-year financial report 2012
Half-year financial report 2011
Half-year financial report 2010
Half-year financial report 2009
Half-year financial report 2008


Prospectus
SPO – March 2010
IPO – November 2007